par  Critchfield, J W;Ho, O;Roberts, Mary;Van Lint, Carine 
;Verdin, Eric 
;Butera, S T
Référence Antiviral chemistry & chemotherapy, 10, 5, page (275-284)
Publication Publié, 1999
          
;Verdin, Eric 
;Butera, S TRéférence Antiviral chemistry & chemotherapy, 10, 5, page (275-284)
Publication Publié, 1999
                                                                                                       
			Article révisé par les pairs
                                                  
        | Titre: | 
  | 
| Auteur: | Critchfield, J W; Ho, O; Roberts, Mary; Van Lint, Carine; Verdin, Eric; Butera, S T | 
| Informations sur la publication: | Antiviral chemistry & chemotherapy, 10, 5, page (275-284) | 
| Statut de publication: | Publié, 1999 | 
| Sujet CREF: | Sciences bio-médicales et agricoles | 
| MeSH keywords: | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine -- pharmacology | 
| Anti-HIV Agents -- pharmacology | |
| Chromatin -- genetics | |
| Chromatin -- physiology | |
| Enzyme Inhibitors -- pharmacology | |
| HIV Infections -- drug therapy | |
| HIV Infections -- virology | |
| HIV-1 -- drug effects | |
| HIV-1 -- genetics | |
| HIV-1 -- growth & development | |
| HIV-1 -- physiology | |
| HL-60 Cells -- metabolism | |
| HL-60 Cells -- virology | |
| Humans | |
| Isoquinolines -- pharmacology | |
| NF-kappa B -- antagonists & inhibitors | |
| NF-kappa B -- physiology | |
| Protein Kinase Inhibitors | |
| RNA, Viral -- drug effects | |
| RNA, Viral -- genetics | |
| Sulfonamides -- pharmacology | |
| Transcription, Genetic -- drug effects | |
| Tumor Necrosis Factor-alpha -- pharmacology | |
| Virus Activation -- drug effects | |
| Virus Activation -- genetics | |
| Virus Latency -- drug effects | |
| Virus Latency -- genetics | |
| Note générale: | Journal Article | 
| Research Support, Non-U.S. Gov't | |
| SCOPUS: ar.j | |
| Langue: | Anglais | 
| Identificateurs: | urn:issn:0956-3202 | 
| info:scp/0032843282 | |
| info:pmid/10574182 | 



